View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Mega Fortris Berhad: 1 director

A director at Mega Fortris Berhad sold 450,000 shares at 0.810MYR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

IOI Properties Group Berhad: 2 directors

Two Directors at IOI Properties Group Berhad bought/sold 9,987,800 shares at between 3.586MYR and 3.587MYR. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...

FPT Corporation: 1 director

A director at FPT Corporation sold 300,000 shares at 0.000VND and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

ARM Research ... (+2)
  • ARM Research
  • Callista Chileke

Seizing Reform Gains | H1:2026 Nigeria Strategy Report

In H1:2025, Nigeria experienced its first taste of macroeconomic stability since 2023, and in our H2:2025 outlook, we asked key questions about how sustainable this recovery could be, given the starting point: inflation in the 30% range, the exchange rate hovering around NGN1,600/USD, weak FX reserves, and extraordinarily high fixed-income yields. Yet 2025 brought a breath of fresh air, and 2026 has the potential to turn this stability into a new norm, if we can effectively seize the gains from ...

Mihail Dimitrov ... (+2)
  • Mihail Dimitrov
  • Veselin Radoychev Please Change Surname

Morning Bulletin - 23 February 2026

The Bulgarian equity market experienced notable intraday volatility in the final trading session of the week, driven by low-volume price swings across a broad range of stocks. Despite these fluctuations, the major indices finished largely unchanged, leaving week-to-date performance broadly flat. SOFIX (1 353.00) closed at the same level as gains in Central Cooperative Bank (CCB, EUR 1.88, +3.30%) and Chimimport (CHIM, EUR 0.49, +4.26%) fully offset declines in Doverie (DUH, EUR 6.90, -2.54%), Fi...

ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Karl Bokvist
  • Lara Mohtadi
 PRESS RELEASE

Forløb af ekstraordinær generalforsamling

Forløb af ekstraordinær generalforsamling Selskabsmeddelelse nr. 09/2026København, den 23. februar 2026 Tirsdag den 23. februar 2026 kl. 10.00 blev der afholdt ekstraordinær generalforsamling i Unlimit Group A/S med følgende dagsorden: Valg af dirigent.Gennemførelse af ændring af aktiernes stykstørrelse (aktiesammenlægning/omvendt aktiesplit) fra kr. 0,01 til kr. 10 med forholdet 1.000:1.Valg af ny revisor.Vedtagelse af nye vedtægter.Eventuelt. AD. punkt 1Generalforsamlingen valgte Christoffer Friis til dirigent. AD. punkt 2Generalforsamlingen godkendte forslaget om gennemførsel af ændr...

 PRESS RELEASE

Harvia completed repurchase of own shares

Harvia completed repurchase of own shares Harvia Plc, Stock Exchange Release, February 23, 2026 at 12:00 pm EET Harvia has completed the repurchase of own shares, which started on 19 February 2026 and ended on 20 February 2026. During that time, Harvia acquired a total of 17,000 own shares for an average price of EUR 39,009 per share. The repurchased shares were acquired based on the authorization given by the Annual General Meeting on 8 April 2025 and shall be used as a part of the Company’s incentive program. Following the repurchase, Harvia Plc holds a total of 20,800 own shares, cor...

 PRESS RELEASE

Harvia on saanut päätökseen omien osakkeidensa hankinnan

Harvia on saanut päätökseen omien osakkeidensa hankinnan Harvia Oyj, Pörssitiedote, 23.2.2026 klo 12:00 Harvia Oyj on saanut päätökseen omien osakkeidensa hankinnan, joka alkoi 19.2.2026 ja päättyi 20.2.2026. Tänä aikana Harvia hankki 17 000 omaa osaketta keskihintaan 39,009 euroa osakkeelta. Osakkeet hankittiin Nasdaq Helsinki Oy:n järjestämässä julkisessa kaupankäynnissä hankintahetken markkinahintaan. Osakkeiden hankinta perustui varsinaisen yhtiökokouksen 8.4.2025 antamaan valtuutukseen ja osakkeet käytetään osana yhtiön kannustinjärjestelmää. Hankinnan jälkeen Harvia Oyj:llä ...

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Simon Brun
ARM Research ... (+2)
  • ARM Research
  • Callista Chileke

Nigerian Breweries Plc 2025FY Earnings Results | Telling the Success o...

After two years of steep losses and a tough macro environment that pressured volumes, Nigerian Breweries’ 2025FY results reveal a company that has not only planned its way back to profitability but also emerged with a stronger balance sheet, a more resilient earnings model, and a clearer strategic focus. Beyond the headline NGN99.1bn profit after tax, the rebound was driven by tighter cost discipline, sharply lower finance costs, and internal restructuring measures, including the shutdown of un...

 PRESS RELEASE

Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-la...

Novo Nordisk A/S: CagriSema demonstrated 23% weight loss in an open-label head-to-head REDEFINE 4 trial in people with obesity, the primary endpoint was not achieved CagriSema achieved 23% weight loss after 84 weeks of treatmentCagriSema 2.4/2.4 mg did not meet the primary endpoint of showing non-inferiority on weight loss compared to tirzepatide 15 mg at 84 weeks1Additional trials are exploring the full weight loss potential of CagriSema, including higher-dose combinations Bagsværd, Denmark, 23 February 2026 – Novo Nordisk today announced headline results from REDEFINE 4, an open-label ph...

Oracle Corporation: Updated credit analysis

Our view of this issuer reflects its risks surrounding the credit impact of the rapid build-out of the AI infrastructure business.

 PRESS RELEASE

Déclaration hebdomadaire des transactions sur CCI 2026 02 16 - 2026 02...

Déclaration hebdomadaire des transactions sur CCI 2026 02 16 - 2026 02 20         CAISSE RÉGIONALE DE CRÉDIT AGRICOLE MUTUEL TOULOUSE 31 Siège Social : 6-7 Place Jeanne d’Arc – 31000 TOULOUSE SIREN 776 916 207  RCS TOULOUSE Société Coopérative à capital variable créée le 18 janvier 1901, régie par le Livre V du Code Monétaire et Financier.Établissement de crédit agréé en qualité de banque mutualiste ou coopérative. Société de courtage d'assurances.Garantie financière et assurance de responsabilité civile professionnelle conformes aux articles L.512-6 et L.512-7 du Code des assurances. ...

Carsten Brzeski
  • Carsten Brzeski

German recovery gains momentum, but tariffs could spoil the party

A strong Ifo index reading in February illustrates what a decent cyclical upswing could look like – if it wasn't for the latest tariff woes

Carole Braudeau
  • Carole Braudeau

Credit Morning 02/23/2026

Eutelsat intends to issue € 1.5bn of new bonds due in 2031 and in 2033|

Private Equity Holding AG: 1 director

A director at Private Equity Holding AG bought 600 shares at 61.000CHF and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Luis Arredondo
  • Luis Arredondo

ALMIRALL: 4Q'25 RESULTS AND CHANGE OF T.P. TO UNDER REVISION (ANÁLISIS...

4Q'25 vs. 4Q'24 Results Sales: € 287.4 M (+11.4% vs. +10.7% BS(e) and +10.3% consensus); EBITDA: € 52.2 M (+3.6% vs. +4.0% BS(e) and +4.8% consensus); EBIT: € 14.3 M (-4.7% vs. +2.7% BS(e) and +14.0% consensus); Net Profit: € 7.1 M (+3450.0% vs. +3447.5% BS(e) and +3650.0% consensus); FY2025 vs. FY2024 Results Sales: € 1.108 Bn (+12.4% vs. +12.3% BS(e) and +12.1% consensus); EBITDA: € 232.9 M (+20.9% vs. +21.0% BS(e) and +21.2% consensus); EBIT: € 81.7 M (+52.7% vs. +54.8% BS(e) and +57.9% conse...

Genolution Inc: 1 director

A director at Genolution Inc bought 810,372 shares at 1,818.000KRW and the significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Sugs Lloyd Ltd: 1 director

A director at Sugs Lloyd Ltd bought 28,000 shares at 99.170INR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch